FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130668816> ?p ?o ?g. }

• W2130668816 endingPage "547" @default.
• W2130668816 startingPage "541" @default.
• W2130668816 abstract "Both adalimumab [ADA] and infliximab [IFX] seem to be effective in the prevention of early postoperative endoscopic recurrence [EPER] after ileocaecal resection in Crohn's disease [CD] patients. There is lack of data with direct comparison between the two agents in the postoperative scenario. The aim of this study was to compare the rates of EPER in patients treated with ADA and IFX after ileocaecal resection for CD.This was a multicentre retrospective analysis of EPER rates in CD patients after ileocaecal resections, from seven referral centres in three countries. Endoscopic recurrence was defined as Rutgeerts' score ≥ i2. The patients were allocated according to treatment to two groups: ADA or IFX. The EPER rates were compared between the two treatment groups.Among the 168 patients included in the database, 96 received anti-tumour necrosis factor [TNF] agents after resection [37 in the ADA and 59 in the IFX groups] and were included in this comparative study. The groups were comparable in all baseline characteristics, mainly age, gender, previous resections, perianal CD, and mono or combination therapy. EPER was identified in 9/37 [24.32%] in the ADA group vs 16/59 [27.12%] in the IFX group [p = 0.815].In this retrospective direct comparison between ADA and IFX therapy after ileocaecal resection, there was no significant difference between the two anti-TNF agents in terms of EPER rates. However, prospective randomised studies are needed to confirm these data and better define the role of each agent in the prevention of EPER." @default.
• W2130668816 created "2016-06-24" @default.
• W2130668816 creator A5006706518 @default.
• W2130668816 creator A5013371282 @default.
• W2130668816 creator A5014211253 @default.
• W2130668816 creator A5017979815 @default.
• W2130668816 creator A5020756972 @default.
• W2130668816 creator A5025613587 @default.
• W2130668816 creator A5033914337 @default.
• W2130668816 creator A5056822373 @default.
• W2130668816 creator A5057429433 @default.
• W2130668816 creator A5058417911 @default.
• W2130668816 creator A5066649201 @default.
• W2130668816 creator A5071958820 @default.
• W2130668816 creator A5082068188 @default.
• W2130668816 creator A5084090560 @default.
• W2130668816 creator A5087271151 @default.
• W2130668816 date "2015-03-28" @default.
• W2130668816 modified "2023-10-16" @default.
• W2130668816 title "Direct Retrospective Comparison of Adalimumab and Infliximab in Preventing Early Postoperative Endoscopic Recurrence After Ileocaecal Resection for Crohn’s Disease: Results from the MULTIPER Database" @default.
• W2130668816 cites W1581169289 @default.
• W2130668816 cites W1752248076 @default.
• W2130668816 cites W1947305094 @default.
• W2130668816 cites W1975958968 @default.
• W2130668816 cites W1980212383 @default.
• W2130668816 cites W2009766383 @default.
• W2130668816 cites W2018575622 @default.
• W2130668816 cites W2033973171 @default.
• W2130668816 cites W2041961077 @default.
• W2130668816 cites W2081689742 @default.
• W2130668816 cites W2105696342 @default.
• W2130668816 cites W2114473465 @default.
• W2130668816 cites W2167468906 @default.
• W2130668816 cites W2170776112 @default.
• W2130668816 doi "https://doi.org/10.1093/ecco-jcc/jjv055" @default.
• W2130668816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25820017" @default.
• W2130668816 hasPublicationYear "2015" @default.
• W2130668816 type Work @default.
• W2130668816 sameAs 2130668816 @default.
• W2130668816 citedByCount "25" @default.
• W2130668816 countsByYear W21306688162015 @default.
• W2130668816 countsByYear W21306688162016 @default.
• W2130668816 countsByYear W21306688162017 @default.
• W2130668816 countsByYear W21306688162018 @default.
• W2130668816 countsByYear W21306688162019 @default.
• W2130668816 countsByYear W21306688162020 @default.
• W2130668816 countsByYear W21306688162021 @default.
• W2130668816 countsByYear W21306688162022 @default.
• W2130668816 countsByYear W21306688162023 @default.
• W2130668816 crossrefType "journal-article" @default.
• W2130668816 hasAuthorship W2130668816A5006706518 @default.
• W2130668816 hasAuthorship W2130668816A5013371282 @default.
• W2130668816 hasAuthorship W2130668816A5014211253 @default.
• W2130668816 hasAuthorship W2130668816A5017979815 @default.
• W2130668816 hasAuthorship W2130668816A5020756972 @default.
• W2130668816 hasAuthorship W2130668816A5025613587 @default.
• W2130668816 hasAuthorship W2130668816A5033914337 @default.
• W2130668816 hasAuthorship W2130668816A5056822373 @default.
• W2130668816 hasAuthorship W2130668816A5057429433 @default.
• W2130668816 hasAuthorship W2130668816A5058417911 @default.
• W2130668816 hasAuthorship W2130668816A5066649201 @default.
• W2130668816 hasAuthorship W2130668816A5071958820 @default.
• W2130668816 hasAuthorship W2130668816A5082068188 @default.
• W2130668816 hasAuthorship W2130668816A5084090560 @default.
• W2130668816 hasAuthorship W2130668816A5087271151 @default.
• W2130668816 hasBestOaLocation W21306688161 @default.
• W2130668816 hasConcept C126322002 @default.
• W2130668816 hasConcept C141071460 @default.
• W2130668816 hasConcept C159110652 @default.
• W2130668816 hasConcept C167135981 @default.
• W2130668816 hasConcept C2777138892 @default.
• W2130668816 hasConcept C2778451229 @default.
• W2130668816 hasConcept C2779134260 @default.
• W2130668816 hasConcept C2779280984 @default.
• W2130668816 hasConcept C2780132546 @default.
• W2130668816 hasConcept C41008148 @default.
• W2130668816 hasConcept C71924100 @default.
• W2130668816 hasConcept C77088390 @default.
• W2130668816 hasConceptScore W2130668816C126322002 @default.
• W2130668816 hasConceptScore W2130668816C141071460 @default.
• W2130668816 hasConceptScore W2130668816C159110652 @default.
• W2130668816 hasConceptScore W2130668816C167135981 @default.
• W2130668816 hasConceptScore W2130668816C2777138892 @default.
• W2130668816 hasConceptScore W2130668816C2778451229 @default.
• W2130668816 hasConceptScore W2130668816C2779134260 @default.
• W2130668816 hasConceptScore W2130668816C2779280984 @default.
• W2130668816 hasConceptScore W2130668816C2780132546 @default.
• W2130668816 hasConceptScore W2130668816C41008148 @default.
• W2130668816 hasConceptScore W2130668816C71924100 @default.
• W2130668816 hasConceptScore W2130668816C77088390 @default.
• W2130668816 hasIssue "7" @default.
• W2130668816 hasLocation W21306688161 @default.
• W2130668816 hasLocation W21306688162 @default.
• W2130668816 hasOpenAccess W2130668816 @default.
• W2130668816 hasPrimaryLocation W21306688161 @default.
• W2130668816 hasRelatedWork W1588288904 @default.
• W2130668816 hasRelatedWork W1701198352 @default.
• W2130668816 hasRelatedWork W1980226479 @default.

• next